Form 3 Filing for GYRE THERAPEUTICS, INC.

This filing is an initial report of beneficial ownership of securities for Ying Luo, Chief Executive Officer of GYRE THERAPEUTICS, INC. It details various stock options held directly and indirectly, with specified exercise prices, expiration dates, and underlying common stock share amounts. Additionally, it reports indirect ownership of common stock by spouse. The filing also includes a Power of Attorney document, appointing representatives to execute and file necessary SEC reports on behalf of Ying Luo, ensuring compliance with Section 16 of the Securities Exchange Act of 1934.